This preliminary investigation exemplifies the prospective significance of UBB and VEGFA expression levels in predicting the effectiveness of TKI treatment in ccRCC, suggesting the reliability of using the UBB/VEGFA ratio as an indicator in future clinical applications. This evidence concerns the gene UBB and nonpapillary renal cell carcinoma.